Isomaltulose doesn't improve glycemic control in diabetes

April 13, 2012
Isomaltulose doesn't improve glycemic control in diabetes

(HealthDay) -- For patients with type 2 diabetes, substitution of sucrose with isomaltulose is not associated with improved glycemic control (measured by hemoglobin A1c [HbA1c] levels) at 12 weeks, according to a study published online April 9 in Diabetes Care.

Stefanie Brunner, from the Technische Universität München in Munich, Germany, and colleagues investigated whether replacement of sucrose with isomaltulose in sweet foods and drinks would improve metabolic control in . A total of 110 patients with type 2 diabetes were randomly allocated to receive sweet foods containing 50 g per day of isomaltulose or sucrose for 12 weeks as part of their habitual diet. The primary outcome parameter was HbA1c at 12 weeks.

In the final analysis of 101 patients, the researchers found that isomaltulose had no significant effect on HbA1c at 12 weeks. Compared with the sucrose group, in the isomaltulose group, triglycerides were significantly lower at 12 weeks. There was no difference in any other secondary parameters.

"Substitution of 50 g/day sucrose by isomaltulose in sweet food and beverages over 12 weeks did not significantly affect HbA1c and most other metabolic and cardiovascular risk parameters," the authors write. "Although the principle of isomaltulose action is unquestionable, a more marked modification of the dietary glycemic index may be required to achieve a clinically significant improvement in in type 2 diabetic patients."

Several of the authors disclosed financial ties to Suedzucker AG, which funded the study.

Explore further: Structured exercise training associated with improved glycemic control for patients with diabetes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Bolus calculation, flexible insulin up diabetes control

February 24, 2012

(HealthDay) -- A structured course teaching the benefits of automated bolus calculator (ABC) use and flexible intensive insulin therapy (FIIT) improves metabolic control and satisfaction in patients with type 1 diabetes, ...

Dapagliflozin aids glycemic control in type 2 diabetes

March 20, 2012

(HealthDay) -- For patients with inadequately controlled type 2 diabetes, treatment with dapagliflozin is associated with improved glycemic control, stabilized insulin dosing, and weight reductions, according to research ...

Study assesses glucose monitoring trends in tweens

April 12, 2012

(HealthDay) -- During the transition to adolescence, children with type 1 diabetes monitor their blood glucose less frequently, resulting in significant increases in HbA1c levels, according to research published online April ...

Recommended for you

Engineered hot fat implants reduce weight gain in mice

August 20, 2015

Scientists at the University of California, Berkeley, have developed a novel way to engineer the growth and expansion of energy-burning "good" fat, and then found that this fat helped reduce weight gain and lower blood glucose ...

Promising progress for new treatment of type 1 diabetes

July 30, 2015

New research from Uppsala University shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study, published in the open access journal Scientific Reports, reveals that administration ...

Bacteria may cause type 2 diabetes

June 1, 2015

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.